Literature DB >> 18591121

Drug-induced tardive syndromes.

M Ortí-Pareja1, F J Jiménez-Jiménez, A Vázquez, M J Catalán, M Zurdo, J A Burguera, P Martínez-Martín, J A Molina.   

Abstract

We reviewed the database of five Movement Disorders Units to establish drugs responsible for tardive syndromes or TS (tardive dyskinesia, dystonia, akathisia, tremor, tics or tourettism, and myoclonus). The diagnostic criteria for TS included: (1) appearance of persistent dyskinesia, dystonia, akathisia, tremor, tics or tourettism, or myoclonus, related to prolonged drug exposure, (2) exclusion of other possible causes of these movement disorders. One-hundred patients fulfilled the diagnostic criteria for TS (26 males, 74 females, mean age 69.4+/-15.8 years). TS were related to 1, 2, 3, 4 and 5 drugs in 58, 27, 9, 5 and 1 patients, respectively. The most frequently offending drugs were antipsychotic drugs, substituted benzamides, thietylperazine and calcium-channel blockers. Seventy-two patients had buccolinguomasticatory syndrome, 30 had tremor, 22 akathisia and 16 dystonia (35 patients had a combination of at least two of these TS). Forty-two patients had coexistent parkinsonism. The TS disappeared following withdrawal of the offending drug in 40 cases. Old age and being female were more frequently associated with TS, with the exception of tardive dystonia. Substituted benzamides, calcium-channel blockers and thiethylperazine (a neuroleptic used for vertigo) were a frequent cause of TS in our series.

Entities:  

Year:  1999        PMID: 18591121     DOI: 10.1016/s1353-8020(99)00015-2

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

Review 1.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

2.  The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

Review 4.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.

Authors:  Haili Zhang; Ming Zheng; Manhong Wu; Dan Xu; Toshihiko Nishimura; Yuki Nishimura; Rona Giffard; Xiaoxing Xiong; Li Jun Xu; J David Clark; Peyman Sahbaie; David L Dill; Gary Peltz
Journal:  Genetics       Date:  2016-03-18       Impact factor: 4.562

6.  An update on tardive dyskinesia: from phenomenology to treatment.

Authors:  Olga Waln; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-07-12

Review 7.  Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.

Authors:  Anelyssa D'Abreu; Joseph H Friedman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-08-31

Review 8.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

9.  Acute Cervical Dystonia Induced by Clebopride.

Authors:  Jin Kyo Choi; Jin Yong Hong
Journal:  Case Rep Neurol Med       Date:  2017-11-28

10.  Interdisciplinary recognizing and managing of drug-induced tardive oromandibular dystonia: two case reports.

Authors:  Merete Bakke; Tove Henriksen; Heidi Bryde Biernat; Torben Dalager; Eigild Møller
Journal:  Clin Case Rep       Date:  2018-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.